Kavita V. Dharmarajan, MD, MSc

Assistant Professor
Department of Radiation Oncology and Palliative Medicine
Mount Sinai Medical Center
1184 Fifth Ave, Box 1236
New York, NY 10029, USA

Biography

Dr. Dharmarajan is a board-certified radiation oncologist with specialized expertise in radiotherapy for palliation in advanced cancer. Dr. Dharmarajan received her medical degree from the Columbia University College of Physicians and Surgeons and Master of Science degree in social health policy from the London School of Economics. She completed her internship in pediatrics at the Massachusetts General Hospital for Children followed by her residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Dharmarajan has published several peer-reviewed articles and conducted an Institutional Review Board-approved prospective research study examining patient decision-making in advanced cancer patients considering palliative radiotherapy. Her research has been funded by an award from the American Medical Association Foundation Seed Grant Award. Dr. Dharmarajan has presented her findings at national meetings and has received several awards for her work including the Research and Education Foundation Award for Outstanding ASTRO Presentation from the American Association of Women Radiologists, an ASTRO Scientific Abstract Award, and the RSNA Roentgen Resident Research Award.

Research Interest

Her research interests include: Integration of radiotherapy into a multidisciplinary treatment approach for patients living with advanced malignancies. In addition to palliative treatments, she is also specialist in radiation for Skin Malignancies, Lymphoma, Myeloma, and Pediatric Malignancies.

Scientific Activities

HONORS & AWARDS

• (2013) Roentgen Research Award, Radiological Society of North America
• (2012) American Medical Association Foundation Seed Grant for Outstanding Young Investigators
• (2012) American College of Radiation Oncology Global Radiation Oncology Workforce Scholarship
• (2012) American Association for Women Radiologists Research & Education Foundation Award for Outstanding ASTRO Presentation in Radiation Oncology
• (2012) Clinical Trials & Innovation in Care Session Abstract Presentation, American Society for Radiation Oncology
• (2012) National Comprehensive Cancer Network Fellows Recognition Program
• (2011) ASTRO Annual Meeting Scientific Abstract Award, American Society for Radiation Oncology
• (2002) Phi Beta Kappa, UT Austin
• (2001) National Science Foundation Undergraduate Research Education Grantee, UT Austin
• (2000) Morgan-Good Research Fellowship Award, UT Southwestern Medical Center
• (2000) Best Poster Award, UT Southwestern Medical Center
• (2000) Third Place, Best Abstract, Medical School Research Forum, UT Southwestern Medical Center
• (2000) National Collegiate Scholars, University of Texas at Austin
• (1999-2002) University Honors, University of Texas at Austin
• (1998) Girl Scouts of America Gold Award

PROFESSIONAL MEMBERSHIPS

• (2013-present) American Society of Clinical Oncology
• (2012-present) American College of Radiation Oncology
• (2011-2013) American Medical Association, Resident/Fellow Section
• (2010-present) American Society for Therapeutic Radiology and Oncology
• (2010-present) New York Roentgen Society Association of Residents in Radiation Oncology
• (2010-present) American Association for Woman Radiologists
• (2009-present) Radiological Society of North America
• (2007-2009) American Academy of Pediatrics

Publications

Peer-Reviewed Manuscripts

1. Illidge T, Specht L, Yahalom J, et al. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group.Int J Radiat Oncol Biol Phys. 2014; 89(1): 49-58. doi: 10.1016/j.ijrobp.2014.01.006
2. Yang JC, Dharmarajan KV, Wexler LH, La Quaglia MP, Happersett L, Wolden SL. Intensity- modulated radiation therapy with dose painting to treat rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2012; 84(3): e371-e377. doi: 10.1016/j.ijrobp.2012.04.022
3. Dharmarajan KV, Wexler LH, Wolden SL. Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: A report on toxicity and efficacy from a prospective pilot phase II study. Pediatr Blood Cancer. 2013; 60(2): 242-247. doi: 10.1002/pbc.24205
4. Dharmarajan KV, Wexler LH, Gavane S, et al. Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2012; 84(4): 996-1002. doi: 10.1016/j.ijrobp.2012.01.077 </a >